| |
| |
|
| Insider
Information: |
Atlas Venture Associates X, Llc |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
5,710,910 |
|
|
Indirect Shares
|
14,874,951 |
|
|
| Direct
Value |
$51,267,653 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
20,585,861 |
|
|
| Total
Value |
$51,267,653 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -125.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dianthus Therapeutics Ord Shs |
DNTH |
10% Owner |
2019-03-20 |
4,117,125 |
2019-03-20 |
0 |
Premium* |
|
|
Kymera Therapeutics, Inc. |
KYMR |
10% Owner |
2021-08-11 |
0 |
2021-08-11 |
5,763,012 |
Premium* |
|
|
Generation Bio Co. |
GBIO |
10% Owner |
2021-04-14 |
0 |
2021-04-14 |
9,111,939 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
10% Owner |
2023-09-16 |
1,593,785 |
2023-09-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IRON |
Disc Medicine, Inc |
10% Owner |
– – • |
2023-09-16 |
4 |
S |
$53.22 |
$112,560 |
D/D |
(2,115) |
1,593,785 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
10% Owner |
– – • |
2023-09-15 |
4 |
S |
$53.16 |
$13,869,125 |
D/D |
(260,894) |
1,595,900 |
0 |
% |
|
| IRON |
Disc Medicine, Inc |
10% Owner |
– – • |
2023-09-14 |
4 |
S |
$53.05 |
$5,010,042 |
D/D |
(94,440) |
1,856,794 |
0 |
% |
|
| KYMR |
Kymera Therapeutics, Inc. |
10% Owner |
– – • |
2021-08-11 |
4 |
S |
$61.00 |
$14,770,113 |
D/D |
(242,133) |
0 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2021-04-14 |
4 |
AS |
$26.40 |
$622,995 |
D/D |
(23,413) |
0 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2021-04-13 |
4 |
AS |
$25.09 |
$1,085,744 |
D/D |
(43,145) |
23,413 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2021-04-12 |
4 |
AS |
$26.07 |
$1,938,229 |
D/D |
(74,124) |
66,558 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2021-04-09 |
4 |
AS |
$27.57 |
$1,205,948 |
D/D |
(43,681) |
140,682 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2021-04-08 |
4 |
AS |
$28.47 |
$1,241,241 |
D/D |
(43,550) |
184,363 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2021-04-07 |
4 |
AS |
$28.48 |
$1,136,671 |
D/D |
(39,864) |
227,913 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
10% Owner |
– – • |
2021-03-12 |
4 |
S |
$56.50 |
$12,958,275 |
D/D |
(229,350) |
0 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
10% Owner |
– – • |
2019-03-20 |
4 |
S |
$17.86 |
$254,416 |
I/I |
(14,245) |
0 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
10% Owner |
– – • |
2019-03-20 |
4 |
A |
$0.00 |
$0 |
I/I |
14,245 |
14,245 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
10% Owner |
– – • |
2019-03-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(726,500) |
4,117,125 |
0 |
- |
|
| DNTH |
Dianthus Therapeutics Ord... |
10% Owner |
– – • |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,746,876 |
4,843,625 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
